Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice - Wikidata - wikimedia - TriplyDB

Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice

Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice

http://www.wikidata.org/entity/Q36371340

about

Innate immunity against Leishmania infections Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens Suppression of LPS-induced inflammatory responses in macrophages infected with Leishmania Keratinocytes determine Th1 immunity during early experimental leishmaniasis.The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens.Gene expression profiling of dendritic cells reveals important mechanisms associated with predisposition to Staphylococcus infections Inflammasomes in host response to protozoan parasites.Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells.Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer.IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity.Langerhans cells are negative regulators of the anti-Leishmania response.The importance of CD11b+ dendritic cells in CD4+ T cell activation in vivo: with help from interleukin 1.Immune modulating effects of NKT cells in a physiologically low dose Leishmania major infection model after αGalCer analog PBS57 stimulation CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice Interleukin-1 receptor type 1 is essential for control of cerebral but not systemic listeriosis.Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice.The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis.Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo.Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach.Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection.Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity.Immune privilege in sites of chronic infection: Leishmania and regulatory T cells.Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells.Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy.The absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in mice Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice Helicobacter pylori infection predicts favorable outcome in patients with gastric cancer.Sex hormones and modulation of immunity against leishmaniasis.NLR proteins and parasitic disease.Cell biology and immunology of Leishmania.Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects.Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance.Differential Activation of Human Keratinocytes by Leishmania Species Causing Localized or Disseminated Disease.Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

P2860

Q27010187-4DB1B440-9DC8-4778-8DA7-98A32623848A Q28539119-9593F9DB-18BD-4159-AF88-47B3945E8603 Q28550483-6789BB66-E670-4417-97AE-0BB482C24F5F Q33669426-309A7D0F-D2C0-4E92-95A8-575B14ABEE62 Q33818803-0C426983-A6E1-4D98-AC1F-15E9B4894742 Q33940781-F56F91FD-A82D-4ECD-BB18-AA21F0A450D4 Q33998838-878263A6-51B8-4DC3-832F-E664B52AF0C7 Q34043775-E700FCB1-DDD3-42AF-8D4A-592514E47A15 Q34249605-3AD07B83-F1A0-40D3-A1D8-2EA375B4FE7E Q34769124-63EBBA25-1236-4C99-A3CD-2950C9F7162E Q34916928-673EEF76-4FC9-4B03-84DB-2020B3829A4E Q34973788-44A2CA9E-0F6A-45D8-829E-BDE01E638767 Q35177839-626BD932-493C-4310-B2D5-99CBF8E5F2AD Q35195426-74012569-EA98-459B-B8E2-894F7BC74161 Q35220391-35398486-6800-4BB6-96D1-1D1807EB3FD7 Q35781375-51C2571A-F533-4781-8385-D1E74D8D272B Q35884239-AE8961A4-01E0-444E-A851-0EC5AE23ABD5 Q35884264-C98D07FF-68A5-48B9-A173-2947F324877E Q35928348-B47279C0-C237-4EC8-A2D0-4F15D6BAC97D Q35968320-3864DBC9-C93B-46FB-8CDF-58F1BA53520D Q36097200-F2F90F7B-0FEB-4E95-A2E8-5C2D5A5EACA9 Q36227843-6C64E5C1-8E9A-4160-8947-7F22581BABBC Q36278760-94065390-82D1-4F58-9135-E70E456CE969 Q36339132-D0339455-497A-4BA3-A758-B6FEFCA2DD55 Q36422047-70693A3B-F011-488A-BE59-FF6D3ABD1F47 Q36526371-B897AD83-227C-4906-A851-45DD4F7B4BBC Q36593757-0A4F2F40-10C9-4421-8B06-19462BC9BDCD Q36597474-FF7F4CA2-2202-43FE-82B7-D13A30C66569 Q36759574-8DB6ACE5-C338-4C0D-A6C6-DE34BBF5C8BE Q36845128-569E93AA-EFD9-452C-9A3F-386BDE58F2A7 Q37118170-65D0ECEE-ED86-496B-BC58-AA04B3D7554D Q37135557-FFF4A789-AA97-4BDD-8E5E-1A07F37A2E96 Q37247990-C8378CBD-85E6-4EF3-9092-D24AEA3D5868 Q37383504-7AB906A3-720A-46EA-A7C1-93F25C85247B Q37409820-8FFF6C72-3DE4-4269-9218-96BC33B7DAA5 Q37846878-207CBD87-7592-4D55-B07D-A7BE96C5DE60 Q37991701-FFA64D3D-E77D-4677-90B6-5C04D590B0F5 Q38043960-8569B7EE-4DB3-44DC-8668-5C56FDB2EB09 Q38710622-EA218EC3-BE4E-4CC9-B9DF-EF752EA8E5DD Q38962452-D4ABA20C-DD08-4290-8620-55F750E57BB8

P2860

Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice

http://www.wikidata.org/entity/Q36371340

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Interleukin 1alpha promotes Th ...... major-susceptible BALB/c mice

@ast

Interleukin 1alpha promotes Th ...... major-susceptible BALB/c mice

@en

type

label

Interleukin 1alpha promotes Th ...... major-susceptible BALB/c mice

@ast

Interleukin 1alpha promotes Th ...... major-susceptible BALB/c mice

@en

prefLabel

Interleukin 1alpha promotes Th ...... major-susceptible BALB/c mice

@ast

Interleukin 1alpha promotes Th ...... major-susceptible BALB/c mice

@en

P1433

Q36371340-2B2FC82B-4518-4C1A-8F5F-4FE752AD7FE2

P1476

Q36371340-ED801111-84A0-4EA7-BA07-8FA604BD3B2B

P2093

Q36371340-027167CD-DABC-4B92-B3AD-7E97D290E1FB

Q36371340-1923513E-C1C7-46F6-9246-A2E734E28901

Q36371340-6A7A709F-14DA-42EE-A4B4-F2589770DB7E

Q36371340-C91E5782-3AAE-45C7-BA7B-A3D6DED9EE1D

Q36371340-D328D9BB-8B0B-4EBE-B33E-F941E7499A9C

Q36371340-DD14E6F9-4F72-45A6-A1FE-2AE517EC9F0E

Q36371340-E97FB4CE-4E1D-4D27-AD70-17098DEB8A3B

P2860

Q36371340-040C9ACF-88CE-4DE1-B943-A7132E447C7B

Q36371340-0A027A85-E5ED-40DF-A2A1-33DCE78D7E95

Q36371340-0B6E9783-4A0D-4922-880C-245EC805F21A

Q36371340-1F1F022C-EC90-49C1-8F59-E902139F16D7

Q36371340-2A36161B-A18E-4F81-A8EB-06C303876F6F

Q36371340-2D3CDD2A-C68D-4A3C-B15A-FB3BDBFA22D8

Q36371340-3777A505-7151-4647-950C-B9138920114F

Q36371340-37C3D89D-C6FA-4E1E-9332-98A86C45EC83

Q36371340-44B6CEE6-BBF1-4D64-ADD4-B80D69AA6CEF

Q36371340-45E176CD-C9A9-4BB5-AB10-A9D95D603A27

P304

Q36371340-D0E912FA-C309-458E-B131-FDEFEBFB60E8

P31

Q36371340-33334953-4464-45A5-B8F4-17A1AA608115

P356

Q36371340-6AD965B0-55B8-4BB8-AA08-CDBB941F288D

P407

Q36371340-5F72F094-355F-457A-9D88-9E75A25B6A87

P433

Q36371340-C5E18895-E53C-4387-9861-5630FC82B075

P478

Q36371340-98678F11-3D06-41E6-AD8A-532F620B5E32

P50

Q36371340-73D2D3A9-EB52-4FE6-878E-9B9EB7A9B343

Q36371340-A4040012-0F40-4EC8-AB2E-C34F2AF26AD9

P577

Q36371340-22DC9B2D-9EBD-4C8E-938B-53E17F128D5D

P5875

Q36371340-60C3B5C2-9EDB-4FD9-B952-AB654FF76205

P698

Q36371340-731D041E-75B5-4910-9FA8-12BCBC06294F

P932

Q36371340-119D333E-39FE-4403-8B29-8433C1B69E71

P356

P1433

Journal of Experimental Medicine

P1476

Interleukin 1alpha promotes Th ...... major-susceptible BALB/c mice

@en

P2093

Cord Sunderkotter

http://www.w3.org/2001/XMLSchema#string

Esther Von Stebut

http://www.w3.org/2001/XMLSchema#string

Jan M Ehrchen

http://www.w3.org/2001/XMLSchema#string

Jurgen Knop

http://www.w3.org/2001/XMLSchema#string

Katharina Molle

http://www.w3.org/2001/XMLSchema#string

Mark C Udey

http://www.w3.org/2001/XMLSchema#string

Susanna Lopez Kostka

http://www.w3.org/2001/XMLSchema#string

P2860

IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells

Selective expression of an interleukin-12 receptor component by human T helper 1 cells

Dendritic cells and the control of immunity

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

Biologic basis for interleukin-1 in disease

T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells.

Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent

IL-1 and IL-18 receptors, and their extended family.

Checkpoints in the regulation of T helper 1 responses.

The immunology of susceptibility and resistance to Leishmania major in mice.

P304

191-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20030159

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

Yasmine Belkaid

Susanna Lopez Kostka

P577

2003-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10661416

http://www.w3.org/2001/XMLSchema#string

P698

12860932

http://www.w3.org/2001/XMLSchema#string

P932

2194079

http://www.w3.org/2001/XMLSchema#string